-
1
Durvalumab and tremelimumab in patients with advanced rare cancer: a multi-centre, non-blinded, open-label phase II basket trialResearch in context
Published 2025-01-01Subjects: Get full text
Article -
2
C-reactive protein as a diagnostic marker for ovarian carcinoma
Published 2025-01-01Subjects: Get full text
Article -
3
-
4
-
5
GNA15 predicts poor outcomes as a novel biomarker related to M2 macrophage infiltration in ovarian cancer
Published 2025-02-01Subjects: “…ovarian carcinoma…”
Get full text
Article -
6
Renal pseudotumor mimicking renal cell carcinoma in an elderly patient with ovarian carcinoma: Case report and literature review
Published 2025-03-01Subjects: Get full text
Article -
7
Unexpected encounters: The surprising link between ovarian cancer and axillary lymphadenopathy
Published 2025-04-01Subjects: “…Ovarian carcinoma…”
Get full text
Article